Stancic Ana

Chief Financial Officer at Omrix Biopharmaceuticals, Inc. · on record since Oct 2, 2007
Director at CHAMPIONS ONCOLOGY, INC. · on record since Apr 2, 2008
Director at K-V Pharmaceutical Co · on record since Jun 21, 2010
Executive VP, COO, PEO, CFO at Viskase Holdings, Inc. · on record since Jan 19, 2012
Director at IMMUNE PHARMACEUTICALS INC · on record since Aug 27, 2013
Chief Accounting Officer at IMCLONE SYSTEMS INC · on record since Mar 17, 2005

Insider trading activity of Stancic Ana

Transactions on record: 54; since Mar 17, 2005

Open-market buys: 3; $28K

Open-market sells: 0

Companies traded: 6; last filing Jan 12, 2015

Figures computed from official regulatory filings — .

Companies where Stancic Ana has traded

IMMUNE PHARMACEUTICALS INC5 tx · $20K · Jan 12, 2015
K-V Pharmaceutical Co8 tx · Sep 27, 2013
Viskase Holdings, Inc.5 tx · Jan 19, 2012
CHAMPIONS ONCOLOGY, INC.5 tx · Jul 18, 2011
Omrix Biopharmaceuticals, Inc.2 tx · Oct 2, 2007
IMCLONE SYSTEMS INC29 tx · $8K · Feb 21, 2007

Track record of Stancic Ana

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Stancic Ana

Co-insiders of Stancic Ana

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
IMMUNE PHARMACEUTICALS INCListing unverified	Jan 12, 2015	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Dec 3, 2014	BuyD (derivative)	2,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Dec 3, 2014	Buy	8,000	2.50 USD	$20K	conv 81ClusterFirst in 12mo	SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Oct 15, 2013	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Oct 15, 2013	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	May 16, 2012	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jan 19, 2012	Other	-45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jan 19, 2012	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jan 19, 2012	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 12, 2011	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Jul 18, 2011	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jun 9, 2011	Award	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jun 9, 2011	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Oct 12, 2010	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 9, 2010	AwardD (derivative)	10,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Feb 23, 2010	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Sep 1, 2009	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Apr 2, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Apr 2, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Omrix Biopharmaceuticals, Inc.Listing unverified	Oct 2, 2007	AwardD (derivative)	60,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Omrix Biopharmaceuticals, Inc.Listing unverified	Oct 2, 2007	Award	8,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
IMMUNE PHARMACEUTICALS INCListing unverified	Jan 12, 2015	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Dec 3, 2014	BuyD (derivative)	2,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Dec 3, 2014	Buy	8,000	2.50 USD	$20K	conv 81ClusterFirst in 12mo	SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Oct 15, 2013	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
IMMUNE PHARMACEUTICALS INCListing unverified	Oct 15, 2013	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 27, 2013	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	May 16, 2012	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jan 19, 2012	Other	-45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jan 19, 2012	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jan 19, 2012	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 12, 2011	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Jul 18, 2011	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jun 9, 2011	Award	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viskase Holdings, Inc.Security delisted	Jun 9, 2011	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Oct 12, 2010	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
K-V Pharmaceutical CoListing unverified	Sep 9, 2010	AwardD (derivative)	10,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Feb 23, 2010	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Sep 1, 2009	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Apr 2, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHAMPIONS ONCOLOGY, INC.Listing on record	Apr 2, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Omrix Biopharmaceuticals, Inc.Listing unverified	Oct 2, 2007	AwardD (derivative)	60,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Omrix Biopharmaceuticals, Inc.Listing unverified	Oct 2, 2007	Award	8,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC